tert-Butyl 2-(2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidin-5-yl)acetate

Catalog No. :
ACOAFO246
CAS No. :
2694731-88-7
Molecular Formula :
C12H13Cl2N3O2
Molecular Weight :
302.16

IUPAC Name:tert-butyl 2-(2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidin-5-yl)acetate

tert-Butyl 2-(2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidin-5-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$186.00Login to see priceInquiryInquiry
100mg95%$269.00Login to see priceInquiryInquiry
250mg95%$379.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-(2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidin-5-yl)acetate
IUPAC Nametert-butyl 2-(2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidin-5-yl)acetate
Molecular FormulaC12H13Cl2N3O2
Molecular Weight302.16
SMILESO=C(OC(C)(C)C)CN1C=CC2=NC(Cl)=NC(Cl)=C21
InChI KeyRUVSHRJHPCAUFP-UHFFFAOYSA-N
Synonym1,1-Dimethylethyl 2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidine-5-acetate
CAS No.2694731-88-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACOAFO246 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVPIQ270 route compound structure diagram
    ACVPIQ27063200-54-4 In Stock
  4. Then
  5. ACOAFO246 route product structure diagram
    ACOAFO2462694731-88-7
Inquiry

2. ACOAFO246 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVPIQ270 route compound structure diagram
    ACVPIQ27063200-54-4 In Stock
  4. Then
  5. ACOAFO246 route product structure diagram
    ACOAFO2462694731-88-7
Inquiry

Comments (0)